Early metabolic changes in metastatic brain tumors after Gamma Knife radiosurgery: 1H-MRS study

被引：17

作者：

Chernov M.F. ^{[1
]}

Hayashi M. ^{[1
]}

Izawa M. ^{[1
]}

Abe K. ^{[2
]}

Usukura M. ^{[2
]}

Ono Y. ^{[2
]}

Kubo O. ^{[1
]}

Hori T. ^{[1
]}

机构：

[1] Department of Neurosurgery, Neurological Institute, Tokyo Women's Medical University, Shinjuku-ku, Tokyo 162-8666

[2] Department of Neuroradiology, Neurological Institute, Tokyo Women's Medical University, Tokyo

来源：

Brain Tumor Pathology | 2004年 / 21卷 / 2期

关键词：

Brain metastasis; Choline; Early metabolic effects; Gamma Knife radiosurgery; N-acetylaspartate; Proton MRS;

D O I：

10.1007/BF02484512

中图分类号：

学科分类号：

摘要：

Evaluation of early metabolic changes in metastatic brain tumors after Gamma Knife radiosurgery was performed by long-echo (TR, 2000ms; TE, 136ms; 128-236 acquisitions) volume-selected single-voxel proton magnetic resonance spectroscopy (MRS). Eighty-five brain metastases in 81 patients were investigated before treatment and 16-18h thereafter. Standard metabolic ratios, namely N-acetylaspartate (NAA)/creatine (Cr), phosphorylcholine/ glycerophosphorylcholine (Cho)/Cr, NAA/Cho, lactate (Lac)/Cr, and mobile lipids (Lip)/Cr, were calculated, and comparison of their values before and after irradiation was done. No volumetric changes of any neoplasm were found in any case on the next day after treatment. At the same time, significant reduction of Cho/Cr (P < 0.001) and NAA/Cr (P < 0.01) ratios on the proton MRS of the tumor was disclosed. Reduction of Cho/Cr ratio was significantly more prominent in neoplasms with higher pretreatment Cho/Cr ratios (P < 0.001) and heterogeneous contrast enhancement (P < 0.01). Reduction of NAA/Cr ratio was predominantly determined by its pretreatment value (P < 0.001). The observed decrease of Cho/Cr ratio probably reflects inhibition of proliferative activity and early apoptotic cell loss, whereas reduction of NAA/Cr may result from radiation-induced modulation of neuronal activity in the peritumoral brain tissue. Serial proton MRS represents a valuable diagnostic tool for evaluation of metabolic changes in intracranial neoplasms after radiosurgical treatment.

引用

页码：63 / 67

页数：4

共 31 条

[1]

Auchter R.M., Lamond J.P., Alexander III E., Et al., A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastases, Int J Radiat Oncol Biol Phys, 35, pp. 27-35, (1996)

[2]

Gerosa M., Nicolato A., Foroni R., Et al., Gamma knife radiosurgery for brain metastases: A primary therapeutic option, J Neurosurg, 97, SUPPL. 5, pp. 515-524, (2002)

[3]

Lutterbach J., Cyron D., Henne K., Et al., Radiosurgery followed by planned observation in patients with one to three brain metastases, Neurosurgery, 52, pp. 1066-1074, (2003)

[4]

Flickinger J.C., Lunsford L.D., Somaza S., Et al., Radiosurgery: Its role in brain metastasis management, Neurosurg Clin N Am, 7, pp. 497-504, (1996)

[5]

Kondziolka D., Lunsford L.D., Flickinger J.C., The radiobiology of radiosurgery, Neurosurg Clin N Am, 10, pp. 157-166, (1999)

[6]

Szeifert G.T., Massager N., DeVriendt D., Et al., Observations of intracranial neoplasms treated with gamma knife radiosurgery, J Neurosurg, 97, SUPPL. 5, pp. 623-626, (2002)

[7]

Szeifert G.T., Salmon I., David P., Et al., Tumor control and growth in a patient with two cerebral metastases treated with the Leksell Gamma Knife, Radiosurgery, 4, pp. 152-161, (2002)

[8]

Nieder C., Andratschke N., Price R.E., Et al., Innovative prevention strategies for radiation necrosis of the central nervous system, Anticancer Res, 22, pp. 1017-1024, (2002)

[9]

Daigle J.L., McBride W.H., Withers H.R., Biological principles of radiotherapy in the central nervous system, Combined Modality Therapy of Central Nervous System Tumors, pp. 53-62, (2001)

[10]

Heesters M.A.A.M., Kamman R.L., Mooyaart E.L., Et al., Localized proton spectroscopy of inoperable brain gliomas: Response to radiation therapy, J Neurooncol, 17, pp. 27-35, (1993)

← 1 2 3 4 →